| Roche Pharma (Schweiz) AG - Xofluza 40 mg, Filmtabletten | | 67426 | | 02 | | Xofluza 40 mg | | Filmtabletten | | J05AX25 | | Baloxavir Marboxil | | 19.02.2020 | | |
| | Composition | | baloxavirum marboxilum 40 mg, lactosum monohydricum 155.8 mg, carmellosum natricum conexum, povidonum K 25, cellulosum microcristallinum, natrii stearylis fumaras, talcum, Überzug: hypromellosum, talcum, E 171, pro compresso obducto corresp. natrium 2.26 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Baloxavirum Marboxilum | 40 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 155.8 mg | | | Natrii Stearylis Fumaras | | | | Povidonum K | 25 | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | PR | PR | B | | Yes | | 004 | 2 | PR | PR | B | | Yes |
|
|
